Rebecca Mosig - Landos Biopharma Executive Development
| LABPDelisted Stock | USD 4.02 0.15 3.60% |
Executive
Rebecca Mosig is Executive Development of Landos Biopharma
| Phone | 540 218 1767 |
| Web | https://landosbiopharma.com |
Landos Biopharma Management Efficiency
The company has return on total asset (ROA) of (0.3938) % which means that it has lost $0.3938 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7067) %, meaning that it created substantial loss on money invested by shareholders. Landos Biopharma's management efficiency ratios could be used to measure how well Landos Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.Landos Biopharma currently holds 27 K in liabilities. Landos Biopharma has a current ratio of 8.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Landos Biopharma's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 7 records | EXECUTIVE Age | ||
| RN MBA | Transcode Therapeutics | N/A | |
| Esq JD | Cardio Diagnostics Holdings | 60 | |
| Daniel MD | Transcode Therapeutics | 72 | |
| Khullani JD | Cardio Diagnostics Holdings | 40 | |
| Alan Freidman | Transcode Therapeutics | N/A | |
| Curtis Lockshin | Xenetic Biosciences | 64 | |
| Calais Pharm | Transcode Therapeutics | 65 | |
Management Performance
| Return On Equity | -0.71 | |||
| Return On Asset | -0.39 |
Landos Biopharma Leadership Team
Elected by the shareholders, the Landos Biopharma's board of directors comprises two types of representatives: Landos Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Landos. The board's role is to monitor Landos Biopharma's management team and ensure that shareholders' interests are well served. Landos Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Landos Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rebecca Mosig, Executive Development | ||
| Patrick Truesdell, Principal Officer | ||
| Timothy MBA, Principal Director | ||
| Jennifer Creel, Interim Officer | ||
| Josep DVM, Advisor | ||
| Fabio MD, Executive Officer | ||
| Gregory Oakes, CEO President |
Landos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Landos Biopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.39 | |||
| Current Valuation | 42.67 M | |||
| Shares Outstanding | 3.13 M | |||
| Shares Owned By Insiders | 9.88 % | |||
| Shares Owned By Institutions | 52.04 % | |||
| Number Of Shares Shorted | 1.43 K | |||
| Price To Book | 2.11 X | |||
| Price To Sales | 2.37 X | |||
| Gross Profit | 18 M |
Pair Trading with Landos Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Landos Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Landos Stock
Moving against Landos Stock
| 0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.82 | EC | Ecopetrol SA ADR | PairCorr |
| 0.78 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.73 | HYMTF | Hyundai Motor | PairCorr |
| 0.71 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Landos Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Landos Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Landos Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Landos Biopharma to buy it.
The correlation of Landos Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Landos Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Landos Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Landos Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |